Home » Topics » Disease categories and therapies » Urology

Urology
RSS

TGI and Quark enter discovery and development collaboration

April 15, 2016

Eli Lilly develops PDE4B inhibitors

April 4, 2016

Kyorin and Kissei sign codevelopment and co-marketing agreement for KRP-114V in Japan

March 31, 2016

Positive topline results from pivotal phase III study of ferric citrate

March 30, 2016

First patients dosed in Quark Pharmaceuticals' pivotal studies

March 15, 2016

Astellas Pharma discloses muscarinic M3 receptor PAMs

March 14, 2016

Tesevatinib receives FDA orphan drug designation for the treatment of ARKPD

March 4, 2016

Oxalate descarboxylase receives FDA orphan drug designation for pediatric hyperoxaluria

March 3, 2016

Thrasos announces successful outcome to phase II trial of THR-184 to prevent acute kidney injury

March 1, 2016

AstraZeneca establishes new collaborations in CKD

Feb. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...